The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy-Reference-Cited by-同舟云学术

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

Published:2024-03-21 Issue:7 Volume:26 Page:1779-1789
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Gómez Rueda Ana,Taus Álvaro,Álvarez Álvarez Rosa,Bernabé-Caro Reyes,Chara Luis,López-Brea Marta,Vilà Laia,Sala González Maria Ángeles,del Barrio Díaz Aldagalán Anabel,Esteban Herrera Beatriz,López Castro Rafael,Álvarez Cabellos Ruth,Doménech Marta,Falagan Sandra,Moreno Vega Alberto,Aguado Carlos,Barba Andrés,Delgado Ureña Maria Teresa,Isla Dolores,Bellido Hernández Lorena,Fírvida Pérez José Luis,Juan-Vidal Óscar,Massutí Bartomeu,Mielgo-Rubio Xabier,Ortega Ana Laura,Catot Silvia,Dómine Manuel,Escoín-Pérez Corina,García Navalón Francisco,Gil-Bazo Ignacio,Muñoz Silvia,Rodríguez-Abreu Delvys,Villatoro Roldán Rosa María,Alonso-Jáudenes Curbera Guillermo,León-Mateos Luis,Padilla Airam,Paredes Lario Alfredo,Sánchez-Torres José Miguel,Garrido Pilar^ORCID,

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12094-024-03404-9.pdf

Reference31 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

2. Estimates for cancer incidence and mortality in 2020, (Lung cancer incidence and mortality), in all countries. Available at https://ecis.jrc.ec.europa.eu/. Accessed 25 Nov 2022.

3. Agbary A, Shalata W, Addeo A, Charpidou A, Cuppens K, Brustugun OT, et al. Real-world journey of unresectable stage III NSCLC patients: current dilemmas for disease staging and treatment. J Clin Med. 2022. https://doi.org/10.3390/jcm11061738.

4. Yoon SM, Shaikh T, Hallman M. Therapeutic management options for stage III non-small cell lung cancer. World J Clin Oncol. 2017;8(1):1–20.

5. Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452–60.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of durvalumab after chemoradiotherapy in locally advanced non-small cell lung cancer in Russia;Meditsinskiy sovet = Medical Council;2024-07-24